Skip to main content
Premium Trial:

Request an Annual Quote

ABI, Integromics Integrate PCR Systems, Data Analysis Software in Biomarker Platform

NEW YORK (GenomeWeb News) – Applied Biosystems and Integromics have worked together to integrate their data handling and PCR systems for biomarker analysis, drug development, and clinical studies, ABI said today.
 
The companies have integrated ABI’s TaqMan arrays and real-time PCR systems with Integromics StatMiner software, which combines data visualization functions with statistical analysis and data mining tools, for use in analyzing real-time gene expression data from biomarker research.
 
ABI and Integromics began the development and co-marketing project, which included assistance from Novartis Pharma, in December 2007.
 
ABI said Novartis is working to promote gene expression biomarkers in drug development studies, and recently used ABI’s TaqMan arrays in a large-scale pilot study.
 
The integrated products support “customers such as Novartis in their gene expression research, by enabling them to turn their data into meaningful information for use in a range of research projects including drug discovery and development,” Xavier Cristina, Applied Biosystems’ European manager for business development in functional analysis, said in a statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.